Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Valmori

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1992
Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccinationD Valmori, A Pessi, E Bianchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2001
The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine productionM D Puente Navazo, D Valmori, C Rüegg
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 allelesD Valmori, A Sabbatini, A Lanzavecchia, et al.
Journal of Immunological Methods|October 19, 1992
T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptidesC Widmann, P Romero, J L Maryanski, et al.
Infection and Immunity|July 1, 1993
Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytesD Grillot, D Valmori, P H Lambert, et al.
Cancer Research|February 15, 1997
Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patientsD Valmori, D Liénard, G Waanders, et al.
International Journal of Cancer|January 15, 1994
Peptide-antibody conjugates for tumour therapy: a MHC-class-II-restricted tetanus toxin peptide coupled to an anti-Ig light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cellsZ Yu, F Healy, D Valmori, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2000
Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expressionM J Pittet, D E Speiser, D Valmori, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic miceY Men, I Miconnet, D Valmori, et al.
European Journal of Immunology|November 1, 1996
Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12G Eberl, B Kessler, L P Eberl, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1992
Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccinationD Valmori, A Pessi, E Bianchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2001
The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine productionM D Puente Navazo, D Valmori, C Rüegg
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 allelesD Valmori, A Sabbatini, A Lanzavecchia, et al.
Journal of Immunological Methods|October 19, 1992
T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptidesC Widmann, P Romero, J L Maryanski, et al.
Infection and Immunity|July 1, 1993
Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytesD Grillot, D Valmori, P H Lambert, et al.
Cancer Research|February 15, 1997
Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patientsD Valmori, D Liénard, G Waanders, et al.
International Journal of Cancer|January 15, 1994
Peptide-antibody conjugates for tumour therapy: a MHC-class-II-restricted tetanus toxin peptide coupled to an anti-Ig light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cellsZ Yu, F Healy, D Valmori, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2000
Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expressionM J Pittet, D E Speiser, D Valmori, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic miceY Men, I Miconnet, D Valmori, et al.
European Journal of Immunology|November 1, 1996
Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12G Eberl, B Kessler, L P Eberl, et al.
Pageof 5